BG51405A1 - Hybridome cellular line secreting monoclonal antibody ageinst human erythrocytec blood group antigen b - Google Patents

Hybridome cellular line secreting monoclonal antibody ageinst human erythrocytec blood group antigen b

Info

Publication number
BG51405A1
BG51405A1 BG9445091A BG9445091A BG51405A1 BG 51405 A1 BG51405 A1 BG 51405A1 BG 9445091 A BG9445091 A BG 9445091A BG 9445091 A BG9445091 A BG 9445091A BG 51405 A1 BG51405 A1 BG 51405A1
Authority
BG
Bulgaria
Prior art keywords
human
monoclonal antibody
blood group
erythrocytec
ageinst
Prior art date
Application number
BG9445091A
Inventor
Anna K Pavlova
Khristo B Taskov
Elena I Georgieva
Original Assignee
Vissh Med I Iv P Pavlov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vissh Med I Iv P Pavlov filed Critical Vissh Med I Iv P Pavlov
Priority to BG9445091A priority Critical patent/BG51405A1/en
Publication of BG51405A1 publication Critical patent/BG51405A1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The hybridoma cell line is applicable for typification of human blood. It carries and expresses the characteristics of the initial cells, divides like cancer cells, and secretes a monoclonal antibody that recognises the human surface-cell erythrocyte blood group antigen B. It is prepared through hybridisation of antibody-producing mouse splenocites from line BALB/c and cells from mouse myeloma line Sp 2/0 Ag 14.
BG9445091A 1991-05-20 1991-05-20 Hybridome cellular line secreting monoclonal antibody ageinst human erythrocytec blood group antigen b BG51405A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG9445091A BG51405A1 (en) 1991-05-20 1991-05-20 Hybridome cellular line secreting monoclonal antibody ageinst human erythrocytec blood group antigen b

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG9445091A BG51405A1 (en) 1991-05-20 1991-05-20 Hybridome cellular line secreting monoclonal antibody ageinst human erythrocytec blood group antigen b

Publications (1)

Publication Number Publication Date
BG51405A1 true BG51405A1 (en) 1993-05-14

Family

ID=3923748

Family Applications (1)

Application Number Title Priority Date Filing Date
BG9445091A BG51405A1 (en) 1991-05-20 1991-05-20 Hybridome cellular line secreting monoclonal antibody ageinst human erythrocytec blood group antigen b

Country Status (1)

Country Link
BG (1) BG51405A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675493A (en) * 1986-01-31 1987-06-23 Eutectic Corporation Gas-constricted arc nozzle

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675493A (en) * 1986-01-31 1987-06-23 Eutectic Corporation Gas-constricted arc nozzle

Similar Documents

Publication Publication Date Title
EP0419574A4 (en) Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same
ES2106195T3 (en) IGG AGLYCOSILATED ANTIBODY ANTI CD3.
AU8727291A (en) Bispecific antibodies, method of production, and uses thereof
DK164510C (en) HUMAN HYBRIDOM, HUMANT MONOCLONAL ANTIBODY OBTAINED THEREOF, APPLICATION OF SUCH ANTIBODY AND PROCEDURE FOR THE PREPARATION OF SUCH ANTIBODY
MX9504802A (en) Anti-egfr single-chain fvs and anti-egfr antibodies.
DK0586002T3 (en) Monoclonal antibodies that recognize the epidermal growth factor receptor, its cells and methods, and preparations thereof
EP0134552A3 (en) Monoclonal antibody with a high affinity for digoxin
NO2006008I2 (en) Natalizumab, anti alpha-4 integrin humanized monoclonal antibody
MD1367B2 (en) Methods of B-cells lymphoma treatment, anti-CD20 antibodies, hybridoma
NL300142I2 (en) Monoclonal antibody against a cytotoxin, hybridoma cell line, which expresses that and method for the preparation of the purified cytotoxin.
EP0212403A3 (en) Monoclonal antibodies to mucin-like human differentiation antigens
PL313260A1 (en) Monoclonal antibodies having properties making them able to cause apoptosis
EP0189688A3 (en) Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
DE3650032D1 (en) ANTICYTOMEGALOVIRAL HUMAN MONOCLONAL ANTIBODIES AND THEIR PRODUCTION.
IT8124862A0 (en) PRODUCTION OF HUMAN MONOCLONAL ANTIBODY USING HUMAN HYBRIDOMAS.
EP0198086A4 (en) Mouse human hybridoma producing antivirus human antibody, process for its preparation, and antivirus human monoclonal antibody.
EP0351045A3 (en) Monoclonal antibody nuh2 capable of inactivating motility of sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen
ATE123066T1 (en) MONOCLONAL ANTIBODIES AND PRODUCTION OF A VACCINE AGAINST HUMAN CANCER ANTIGENS BY IMMUNIZATION WITH HUMAN AND ANIMAL MUCIN AND WITH SYNTHETIC GLUCIDEN CARRIER CONJUGATES.
AU629954B2 (en) Monoclonal antibodies directed against activated microglial cells, hybridomas secreting these monoclonal antibodies, antigen recognized by these monoclonal antibodies and their applications
BG51405A1 (en) Hybridome cellular line secreting monoclonal antibody ageinst human erythrocytec blood group antigen b
CA2012264A1 (en) Anti-human sperm antibody and its production and use
EP0155172A3 (en) Anti-human lung cancer monoclonal antibodies
ES2000615A6 (en) Monoclonal antibodies against tumour-associated glycoproteins, process for their preparation and their use.
EP0554458A4 (en) Immunoassay, monoclonal antibody and hybridoma
DE3484456D1 (en) MONOCLONAL ANTIBODIES.